語系:
繁體中文
English
說明(常見問題)
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Nano drug delivery for cancer therapy = principles and practices /
紀錄類型:
書目-語言資料,印刷品 : Monograph/item
正題名/作者:
Nano drug delivery for cancer therapy/ edited by Firdos Alam Khan.
其他題名:
principles and practices /
其他作者:
Khan, Firdos Alam.
出版者:
Singapore :Springer Nature Singapore : : 2023.,
面頁冊數:
xiii, 251 p. :ill., digital ; : 24 cm.;
Contained By:
Springer Nature eBook
標題:
Cancer Nanotechnology. -
電子資源:
https://doi.org/10.1007/978-981-99-6940-1
ISBN:
9789819969401
Nano drug delivery for cancer therapy = principles and practices /
Nano drug delivery for cancer therapy
principles and practices /[electronic resource] :edited by Firdos Alam Khan. - Singapore :Springer Nature Singapore :2023. - xiii, 251 p. :ill., digital ;24 cm.
Ch 1 Significance of nano-drug delivery in cancer therapy, application of nanoparticles in overcoming drug resistance, targeted therapy, and Immunotherapy -- Ch 2 Synthesis of different types, shapes, and sizes of nanocarriers using synthetic and biological approaches -- Ch 3 Synthesis of nanocarriers loaded with anti-cancer drugs by using functionalization or conjugations, encapsulation methods -- Ch 4 Nano-Drug Carriers for Chemotherapeutic Agents Delivery in Cancer Disease Treatment -- Ch 5 Testing Of Nanocarriers Loaded with Chemotherapeutic Agents in the Animal Models of Cancers - Preclinical Trials for Efficacy and Safety Profiling of Nanocarriers -- Ch 6 Testing Of Nanocarriers Loaded With Chemotherapeutic Agents In The Animal Models Of Cancers - Preclinical Trials For Efficacy And Safety Profiling Of Nanocarriers -- Ch 7 Nanocarriers-Based Products In The Market, Fda Approval, Commercialization Of Nanocarriers, and Global Market -- Ch 8 Limitations of Nanocarriers Such as Cell and Tissue Toxicity, Genotoxicity, Scale-Up of Nanomaterials -- Ch 9 Health And Environmental Hazards Associated With The Synthesis Of Nanomaterials-Respiratory Diseases, Government Regulations, Ethical Issues -- Ch 10 Future trends and innovation in nano drug delivery for cancer therapy, application of siRNA (nanoparticle-based RNA) therapy, Ultrasound linked nano-cancer therapeutics, and application of exosomes-based cancer therapy.
This book discusses the various modes and methods of nano-based drug delivery in different types of cancers such as colon, breast, cervical, ovarian, and lung cancer. It reviews the significance of nano drug delivery in cancer therapy, the application of nanoparticles in overcoming drug resistance, targeted therapy, and immunotherapy. The book also covers topics related to the synthesis of different types, shapes, and sizes of nanocarriers using synthetic and biological approaches. Further, a chapter explores the synthesis of nanocarriers loaded with anti-cancer drugs by using functionalization or conjugations and encapsulation methods. The book also examines the nanocarriers as delivery vehicles for chemotherapeutic agents against cancers using in vitro and animal models of cancers, preclinical trials for efficacy, and safety profiling of nanocarriers. Finally, future trends and innovation in nano drug delivery for cancer therapy, application of siRNA (nanoparticle-based RNA) therapy, ultrasound-linked nano-cancer therapeutics, and application of exosome-based cancer therapy topics are discussed. Towards the end, the book examines the limitations of nanocarriers, including the cell and tissue toxicity, genotoxicity, and scale-up of nanomaterials, health and environmental hazards associated with nanoformulation synthesis, respiratory diseases, government regulations, and ethical issues.
ISBN: 9789819969401
Standard No.: 10.1007/978-981-99-6940-1doiSubjects--Topical Terms:
1366629
Cancer Nanotechnology.
LC Class. No.: RC271.C5
Dewey Class. No.: 616.994061
Nano drug delivery for cancer therapy = principles and practices /
LDR
:03887nam a2200349 a 4500
001
1120779
003
DE-He213
005
20240108064052.0
006
m d
007
cr nn 008maaau
008
240612s2023 si s 0 eng d
020
$a
9789819969401
$q
(electronic bk.)
020
$a
9789819969395
$q
(paper)
024
7
$a
10.1007/978-981-99-6940-1
$2
doi
035
$a
978-981-99-6940-1
040
$a
GP
$c
GP
041
0
$a
eng
050
4
$a
RC271.C5
072
7
$a
TBN
$2
bicssc
072
7
$a
TCB
$2
bicssc
072
7
$a
SCI010000
$2
bisacsh
072
7
$a
TBN
$2
thema
072
7
$a
TCB
$2
thema
082
0 4
$a
616.994061
$2
23
090
$a
RC271.C5
$b
N186 2023
245
0 0
$a
Nano drug delivery for cancer therapy
$h
[electronic resource] :
$b
principles and practices /
$c
edited by Firdos Alam Khan.
260
$a
Singapore :
$c
2023.
$b
Springer Nature Singapore :
$b
Imprint: Springer,
300
$a
xiii, 251 p. :
$b
ill., digital ;
$c
24 cm.
505
0
$a
Ch 1 Significance of nano-drug delivery in cancer therapy, application of nanoparticles in overcoming drug resistance, targeted therapy, and Immunotherapy -- Ch 2 Synthesis of different types, shapes, and sizes of nanocarriers using synthetic and biological approaches -- Ch 3 Synthesis of nanocarriers loaded with anti-cancer drugs by using functionalization or conjugations, encapsulation methods -- Ch 4 Nano-Drug Carriers for Chemotherapeutic Agents Delivery in Cancer Disease Treatment -- Ch 5 Testing Of Nanocarriers Loaded with Chemotherapeutic Agents in the Animal Models of Cancers - Preclinical Trials for Efficacy and Safety Profiling of Nanocarriers -- Ch 6 Testing Of Nanocarriers Loaded With Chemotherapeutic Agents In The Animal Models Of Cancers - Preclinical Trials For Efficacy And Safety Profiling Of Nanocarriers -- Ch 7 Nanocarriers-Based Products In The Market, Fda Approval, Commercialization Of Nanocarriers, and Global Market -- Ch 8 Limitations of Nanocarriers Such as Cell and Tissue Toxicity, Genotoxicity, Scale-Up of Nanomaterials -- Ch 9 Health And Environmental Hazards Associated With The Synthesis Of Nanomaterials-Respiratory Diseases, Government Regulations, Ethical Issues -- Ch 10 Future trends and innovation in nano drug delivery for cancer therapy, application of siRNA (nanoparticle-based RNA) therapy, Ultrasound linked nano-cancer therapeutics, and application of exosomes-based cancer therapy.
520
$a
This book discusses the various modes and methods of nano-based drug delivery in different types of cancers such as colon, breast, cervical, ovarian, and lung cancer. It reviews the significance of nano drug delivery in cancer therapy, the application of nanoparticles in overcoming drug resistance, targeted therapy, and immunotherapy. The book also covers topics related to the synthesis of different types, shapes, and sizes of nanocarriers using synthetic and biological approaches. Further, a chapter explores the synthesis of nanocarriers loaded with anti-cancer drugs by using functionalization or conjugations and encapsulation methods. The book also examines the nanocarriers as delivery vehicles for chemotherapeutic agents against cancers using in vitro and animal models of cancers, preclinical trials for efficacy, and safety profiling of nanocarriers. Finally, future trends and innovation in nano drug delivery for cancer therapy, application of siRNA (nanoparticle-based RNA) therapy, ultrasound-linked nano-cancer therapeutics, and application of exosome-based cancer therapy topics are discussed. Towards the end, the book examines the limitations of nanocarriers, including the cell and tissue toxicity, genotoxicity, and scale-up of nanomaterials, health and environmental hazards associated with nanoformulation synthesis, respiratory diseases, government regulations, and ethical issues.
650
2 4
$a
Cancer Nanotechnology.
$3
1366629
650
2 4
$a
Cancer Biology.
$3
1388882
650
1 4
$a
Nanobiotechnology.
$3
989992
650
0
$a
Drug delivery systems.
$3
581921
650
0
$a
Cancer
$x
Chemotherapy
$x
Technological innovations.
$3
1436265
700
1
$a
Khan, Firdos Alam.
$3
1090808
710
2
$a
SpringerLink (Online service)
$3
593884
773
0
$t
Springer Nature eBook
856
4 0
$u
https://doi.org/10.1007/978-981-99-6940-1
950
$a
Medicine (SpringerNature-11650)
筆 0 讀者評論
多媒體
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼[密碼必須為2種組合(英文和數字)及長度為10碼以上]
登入